The nomogram shows good discrimination, calibration, and clinical utility for identifying RA patients at elevated risk of osteoporosis, aiding in targeted screening and early intervention.
Limitations:
Model performance in diverse populations remains untested.
Prospective multicenter external validation is necessary before clinical application.
Conclusion:
The proposed nomogram is a promising tool for predicting osteoporosis risk in RA patients, but further validation is required.
